These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9769815)
1. Focal brain lesions: effect of single-voxel proton MR spectroscopic findings on treatment decisions. Adamson AJ; Rand SD; Prost RW; Kim TA; Schultz C; Haughton VM Radiology; 1998 Oct; 209(1):73-8. PubMed ID: 9769815 [TBL] [Abstract][Full Text] [Related]
2. Brain tumors: localized H-1 MR spectroscopy at 0.5 T. Prost R; Haughton V; Li SJ Radiology; 1997 Jul; 204(1):235-8. PubMed ID: 9205253 [TBL] [Abstract][Full Text] [Related]
3. Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. Norfray JF; Tomita T; Byrd SE; Ross BD; Berger PA; Miller RS AJR Am J Roentgenol; 1999 Jul; 173(1):119-25. PubMed ID: 10397111 [TBL] [Abstract][Full Text] [Related]
4. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660 [TBL] [Abstract][Full Text] [Related]
5. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Bartella L; Thakur SB; Morris EA; Dershaw DD; Huang W; Chough E; Cruz MC; Liberman L Radiology; 2007 Oct; 245(1):80-7. PubMed ID: 17885182 [TBL] [Abstract][Full Text] [Related]
6. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. Tien RD; Lai PH; Smith JS; Lazeyras F AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372 [TBL] [Abstract][Full Text] [Related]
7. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients. Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751 [TBL] [Abstract][Full Text] [Related]
8. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic impact of proton MR-spectroscopy versus image-guided stereotactic biopsy. Setzer M; Herminghaus S; Marquardt G; Tews DS; Pilatus U; Seifert V; Zanella F; Lanfermann H Acta Neurochir (Wien); 2007; 149(4):379-86. PubMed ID: 17380247 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance spectroscopy in focal brain lesions. Alam MS; Sajjad Z; Hafeez S; Akhter W J Pak Med Assoc; 2011 Jun; 61(6):540-3. PubMed ID: 22204206 [TBL] [Abstract][Full Text] [Related]
11. MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment. Segebarth CM; Balériaux DF; Arnold DL; Luyten PR; den Hollander JA Radiology; 1987 Oct; 165(1):215-9. PubMed ID: 3628774 [TBL] [Abstract][Full Text] [Related]
12. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Prando A; Kurhanewicz J; Borges AP; Oliveira EM; Figueiredo E Radiology; 2005 Sep; 236(3):903-10. PubMed ID: 16118169 [TBL] [Abstract][Full Text] [Related]
13. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. Castillo M; Kwock L; Scatliff J; Mukherji SK Magn Reson Imaging Clin N Am; 1998 Feb; 6(1):1-20. PubMed ID: 9449737 [TBL] [Abstract][Full Text] [Related]
14. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects. Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882 [TBL] [Abstract][Full Text] [Related]
16. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence]. Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors. Lee J; Yamaguchi T; Abe A; Shizukuishi K; Uemura H; Miyagi E; Sakata K; Inoue T Radiat Med; 2004; 22(3):148-54. PubMed ID: 15287529 [TBL] [Abstract][Full Text] [Related]